Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03123328 · ClinicalTrials.gov registry record · NA
Evaluation of Non-Invasive Hemoglobin in Trauma Patients
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 380
- Enrollment target
NCT03123328 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 380 participants.
The verdict
NCT03123328, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
Study Summary
This is a prospective, non-blinded, non-randomized, interventional study of the Masimo pulse oximeter and sensors in a trauma setting
Interventions
- DEVICE Radical-7 Pulse CO-Oximeter and sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2017-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03123328
The ClinicalTrials.gov registry entry for NCT03123328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radical-7 Pulse CO-Oximeter and sensor is the first listed.
NCT03123328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03123328 about?
NCT03123328 is a clinical study titled "Evaluation of Non-Invasive Hemoglobin in Trauma Patients". This is a prospective, non-blinded, non-randomized, interventional study of the Masimo pulse oximeter and sensors in a trauma setting
What is the current status of trial NCT03123328?
This trial is currently completed. It is a NA study. The enrollment target is 380 participants. The study started on 2016-06-30. Estimated completion is 2017-03-25.
What interventions are being tested in trial NCT03123328?
The interventions under investigation include: Radical-7 Pulse CO-Oximeter and sensor (DEVICE).
Who is sponsoring clinical trial NCT03123328?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.